Back
Capricor Therapeutics Quote, Financials, Valuation and Earnings
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here
Buy
59
CAPR
Capricor Therapeutics
Last Price:
18.47
Seasonality Move:
15.69%
7 Day Trial
ALL ACCESS PASS
$
7
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.Capricor Therapeutics Price Quote
$18.47
+1.56 (+9.23%)
(Updated: November 14, 2024 at 5:55 PM ET)
Capricor Therapeutics Key Stats
Buy
59
Capricor Therapeutics (CAPR)
is a Buy
Day range:
$16.77 - $18.58
52-week range:
$2.80 - $23.40
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
19.95
P/B ratio:
51.2%
Volume:
1.7M
Avg. volume:
2.4M
1-year change:
495.42%
Market cap:
$589M
Revenue:
$25.2M
EPS:
$-0.89
How Much Does Capricor Therapeutics Make?
-
How Much Are Capricor Therapeutics's Sales Annually?
CAPR Revenues are $25.2M -
How Much Profit Does Capricor Therapeutics's Make A Year?
CAPR net income is -$22.3M
Is Capricor Therapeutics Growing As A Company?
-
What Is Capricor Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.01% -
What Is Capricor Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Capricor Therapeutics Stock Price Performance
-
Did Capricor Therapeutics Stock Go Up Last Month?
Capricor Therapeutics share price went down by -4.84% last month -
Did CAPR's Share Price Rise Over The Last Year?
CAPR share price rose by 495.42% over the past 1 year
What Is Capricor Therapeutics 52-Week High & Low?
-
What Is Capricor Therapeutics’s 52-Week High Share Price?
Capricor Therapeutics has traded as high as $23.40 over the past 52 weeks -
What Is Capricor Therapeutics’s 52-Week Low Share Price?
Capricor Therapeutics has traded as low as $2.80 over the past 52 weeks
Capricor Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Capricor Therapeutics?
-
How Much Debt Does Capricor Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Capricor Therapeutics Have?
Cash and short term investments quarterly total is $29.5M -
What Is Capricor Therapeutics’s Book Value Per Share?
Book value per share is 0.36
Is Capricor Therapeutics Cash Flow Positive?
-
What Is CAPR Cash Flow From Operations?
Cash flow from operations (TTM) is -$33.9M -
What Is Capricor Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $27.7M -
What Is Capricor Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $7.1M
Capricor Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
CAPR return on invested capital is -261.27% -
What Is Capricor Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -60.85% -
What Is CAPR Return On Equity?
ROE is a measure of profitability and is -261.27%
Capricor Therapeutics Earnings Date & Stock Price
-
What Is Capricor Therapeutics's Stock Price Today?
A single share of CAPR can be purchased today for 16.91 -
What Is Capricor Therapeutics’s Stock Symbol?
Capricor Therapeutics trades on the nasdaq under the ticker symbol: CAPR -
When Is Capricor Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Capricor Therapeutics is scheduled on February 28, 2025 -
When Is CAPR's next ex-dividend date?
Capricor Therapeutics's next ex-dividend date is November 15, 2024 -
How To Buy Capricor Therapeutics Stock?
You can buy Capricor Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Capricor Therapeutics Competitors
-
Who Are Capricor Therapeutics's Competitors?
Below is a list of companies who compete with Capricor Therapeutics or are related in some way:
Capricor Therapeutics Dividend Yield
-
What Is CAPR Dividend Yield?
Capricor Therapeutics’s dividend yield currently is 0% -
What Is Capricor Therapeutics’s Payout Ratio?
Capricor Therapeutics’s payout ratio is 0% -
When Did Capricor Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 15, 2024 -
What Is Capricor Therapeutics’s Dividend Per Share?
Capricor Therapeutics pays a dividend of $0.00 per share
Capricor Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -5% |
| Revenue: | 1.38% | 8.39% |
Analyst Recommendations
| Buy Recommendations: | 3 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 40.67 |
| Upside from Last Price: | 140.49% |